GSK names head of infectious diseases R&D unit

显然是个中国人。人家没改洋名字，不也照样出人头地。

British drugmaker GlaxoSmithKline said Wednesday it has appointed Zhi Hong
to lead a new research unit aimed at the discovery of therapies for
infectious diseases.

Hong, currently executive vice president and chief scientific officer for
San Diego-based Ardea Biosciences, will assume the new position effective
April 23.

In his new role, Hong will oversee discovery operations for treatments for
diseases such as HIV, AIDS and viral hepatitis and for bacterial resistance
to currently marketed antibiotics.

GSK officials said they have yet to determine where Hong will be based but
that it will likely be either in Pennsylvania or in Research Triangle Park.

Hong will run GSK's Center of Excellence for Drug Discovery for infectious
diseases, a research and development facility being developed specifically
to target infectious disease drug research and development.

GSK's research and development operations include nine CEDDs organized by
therapeutic area or technology.